Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Viatris entered into a merger agreement with Pacira BioSciences under which a Viatris subsidiary will launch a tender offer to acquire all Pacira shares for $36.50 each in cash. The deal is subject to customary conditions, including HSR review and a minimum tender condition.
Viatris will pay $36.50 per share in cash for Pacira BioSciences, a roughly 45% premium to Pacira’s prior close, in a deal set to close by year-end.
Viatris (VTRS) has agreed to buy Pacira Biosciences (PCRX) for $1.65B in cash, at $36.50 per share.